Assembly Biosciences
ASMB
48 hedge funds and large institutions have $92.3M invested in Assembly Biosciences in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 9 closing their positions.
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 52 → 48 (-4)
22% less capital invested
Capital invested by funds: $118M → $92.3M (-$26M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.92M |
| 2 |
VAM
Visium Asset Management
New York
|
+$908K |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$244K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$208K |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$3.05M |
| 2 |
Morgan Stanley
New York
|
-$536K |
| 3 |
Millennium Management
New York
|
-$240K |
| 4 |
PP
PDT Partners
New York
|
-$207K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$189K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
AQR Capital Management
Greenwich,
Connecticut
| – | -$189K | -1,644 | Closed |
|
|
OPPM
52
Opus Point Partners Management
New York
| – | -$143K | -1,250 | Closed |
|
53
Goldman Sachs
New York
| – | -$120K | -1,042 | Closed |
|
|
PAM
54
Panagora Asset Management
Boston,
Massachusetts
| – | -$45K | -392 | Closed |
|
|
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$11K | -99 | Closed |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$5K | -48 | Closed |
|
57
Barclays
London,
United Kingdom
| – | -$1K | -6 | Closed |
|
ASMB Hedge Fund Activity: Q4 2015 in Review
48 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2015, worth a combined $92.3M — down 22% from $118M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ASMB and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 18 added.
The largest buyer was EcoR1 Capital, adding an estimated $1.92M. The largest seller was HealthCor Management, exiting entirely with an estimated $3.05M sold.
- 48 institutional investors held Assembly Biosciences (ASMB) as of Q4 2015, down from 52 in Q3 2015.
- Funds reported $92.3M of Assembly Biosciences stock for Q4 2015, down 22% quarter-over-quarter.
- 5 funds opened new Assembly Biosciences positions in Q4 2015 and 9 closed out, a net change of -4 holders.
- The largest Assembly Biosciences buyer in Q4 2015 was EcoR1 Capital, an estimated $1.92M added.
- The largest Assembly Biosciences seller in Q4 2015 was HealthCor Management, an estimated $3.05M sold.
Based on aggregated 13F filings for Q4 2015.